Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Feb 10, 2021 8:42am
73 Views
Post# 32522853

RE:RE:RE:CBDT.CN Secures MDEL for Saliva Test

RE:RE:RE:CBDT.CN Secures MDEL for Saliva Test

Missing out on what? Predictions now are that vaccinations will be ongoing well into 2022. There is no timeline yet for the developing world except that they are lagging far behind in support to acquire vaccines. Airlines are essentially shutting down all over the world as they recognize that restrictions on the travelling public continue to escalate. Thus Thrm is not missing out at all because there is not A SINGLE test on the market yet that meets the demand and the following criterion ....rapid, point of care, accurate and INEXPENSIVE. All of the most recent NRs from Thrm suggest that is their mandate for SCV2. 

Trust me, if their was a device out their already it would be a billion dollar company. There isn't one.

Cheers!

By the way and in terms of TIMING ....CBDT isn't catching the tail ....we're still in the MIDDLE of a pandemic .....with governments all over the world scrambling to put things in order.


Y2k2112 wrote: I  just like to remind you about timing and establishment , The biggest question is how far the test can extend?  based on that CBDT can capture a tail but Therma seems to be missing out.

 

<< Previous
Bullboard Posts
Next >>